Junko Iwano

Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo

K. Tomizuka, J. Enokizono, W. Piao, 2018, Oncotarget.

Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis.

Yasuyoshi Watanabe, Hidefumi Mukai, K. Hatanaka, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Novel anticarcinoembryonic antigen antibody–drug conjugate has antitumor activity in the existence of soluble antigen

Ryosuke Nakano, K. Tomizuka, J. Enokizono, 2017, Cancer medicine.

Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity

T. Doi, Moto Kajiwara, K. Inui, 2009, Journal of Human Genetics.

One-Step Conjugation Method for Site-Specific Antibody-Drug Conjugates through Reactive Cysteine-Engineered Antibodies.

Kazuhiro Masuda, Tsuyoshi Yamaguchi, Eri Taguchi, 2016, Bioconjugate chemistry.

Targeted delivery to macrophages and dendritic cells by chemically modified mannose ligand-conjugated siRNA

K. Tomizuka, Hiroto Iwai, Yoji Yamada, 2022, Nucleic acids research.

Impact of Different Selectivity between Soluble and Membrane-bound Forms of Carcinoembryonic Antigen (CEA) on the Target-mediated Disposition of Anti-CEA Monoclonal Antibodies

T. Murakami, J. Enokizono, Junko Iwano, 2019, Drug Metabolism and Disposition.